PUBLIC COMPANY
save$INOINOVIO PHARMACEUTICALS, INC.
$INOPlymouth Meeting, PA, USupdated 1mo ago
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 11pre_registration
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
- phase2INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
- phase2Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers
- phase2INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
- phase3REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
- phase3Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
- phase2Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)
- phase3REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Insider activity
source: SEC Form 4routine RSU / option mechanics (3)
- Mar 31, 26tax coverSumner Michael John · Chief Medical Officer1,223 sh
- Mar 31, 26option exerciseSumner Michael John · Chief Medical Officer4,292 sh
- Mar 31, 26option exerciseSumner Michael John · Chief Medical Officer4,292 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 28m ago
Found something off?
comments(0)
5-min edit window · permanent after that